Cytocom
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cytocom generated cash of -$2,372,985, which is more than the previous year. Cash used in financing activities reached the amount of $3,165,640 last year. Net change in cash is therefore $820,294.
Cash Flow
| 2011 | -16.90M | -6.06M | 34.76M |
|---|---|---|---|
| 2012 | -20.64M | 1.37M | 21.51M |
| 2013 | -23.10M | 560.70K | 7.26M |
| 2014 | -14.45M | -1.78M | 10.59M |
| 2015 | -12.08M | -10.27M | 24.93M |
| 2016 | -5.03M | 5.67M | 539.99K |
| 2017 | -6.61M | 3.88M | 0 |
| 2018 | -4.61M | 3.96M | 55.21K |
| 2019 | -2.66M | 156.78K | 0 |
| 2020 | -2.37M | 55.44K | 3.16M |
CBLI Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.12M | 3.61M | 4.23M | 6.90M | 5.91M | 3.10M | 10.04M | 25.65M | 22.87M | 10.91M |
Operating activities | ||||||||||
Net income | -2.39M | -2.64M | -3.61M | -9.70M | -2.65M | -12.63M | 1.62M | -17.26M | -18.23M | -4.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 11.44K | 13.78K | 18.17K | 21.08K | 63.45K | 140.13K | 200.79K | 471.20K | 479.59K | 525.51K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.47M | 2.53M | 4.04M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.47M | 2.53M | 4.04M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 380.14K | -68.47K | 431.32K | -201.76K | 300.76K | -414.06K | 629.39K | -416.49K | 1.73M | 3.64M |
Inventories | -1.10M | 0 | 0 | -12.43M | -15.27M | 4.23M | -6.25M | -16.84M | 0 | 0 |
Accounts payable | -225.17K | 0 | 0 | -138.57K | 124.00K | -833.94K | 459.33K | -713.50K | 609.52K | -348.28K |
Cash generated by operating activities | -2.37M | -2.66M | -4.61M | -6.61M | -5.03M | -12.08M | -14.45M | -23.10M | -20.64M | -16.90M |
Investing activities | ||||||||||
Purchases Of Investments | -679.17K | -1.24M | -7.73M | -8.63M | -17.22M | -16.87M | -1.40M | 0 | -5.22M | -5.52M |
Investments In Property Plant And Equipment | 0 | -1.54K | -27.87K | -4.40K | -10.24K | 5.91K | -20.22K | -139.49K | -178.27K | -655.55K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 3M | -2M | 0 | 0 | 0 |
Cash generated by investing activities | 55.44K | 156.78K | 3.96M | 3.88M | 5.67M | -10.27M | -1.78M | 560.70K | 1.37M | -6.06M |
Financing activities | ||||||||||
Common Stock Issued | 2.78M | 0 | 0 | 0 | 539.99K | 27.60M | 9.69M | 0 | 15.67M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | -83.63K | -78.12K | -52.41K | 0 |
Cash used in financing activities | 3.16M | 0 | 55.21K | 0 | 539.99K | 24.93M | 10.59M | 7.26M | 21.51M | 34.76M |
Net Change In Cash | 820.29K | -2.49M | -613.31K | -2.67M | 983.39K | 2.81M | -6.94M | -15.60M | 2.77M | 11.95M |
Cash at end of period | 1.94M | 1.12M | 3.61M | 4.23M | 6.90M | 5.91M | 3.10M | 10.04M | 25.65M | 22.87M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |